PD-1/PD-L1-IN-29 is a potent PD-1/PD-L1 inhibitor with an IC50 of 6.1 nM; it disrupts PD-1/PD-L1 interaction by binding to PD-L1, induces PD-L1 dimerization and internalization, enhances PD-L1 localization to the endoplasmic reticulum, and exhibits anticancer activity.